Adil Maarouf

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Fatal cerebral toxoplasmosis in a patient with multiple sclerosis treated with natalizumab.

Fatal cerebral toxoplasmosis in a patient with multiple sclerosis treated with natalizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?

Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria.

Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria.

Journal: Neurology

Published: March 17, 2026

"Time is Brain" also in multiple sclerosis: Fifteen years later, a fully consolidated concept.

"Time is Brain" also in multiple sclerosis: Fifteen years later, a fully consolidated concept.

Journal: Revue neurologique

Published: December 18, 2025

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Journal: Revue neurologique

Published: November 18, 2025

Immune checkpoint inhibitor - associated optic neuropathy: Two illustrative cases and therapeutic implications.

Immune checkpoint inhibitor - associated optic neuropathy: Two illustrative cases and therapeutic implications.

Journal: Revue neurologique

Published: October 06, 2025

Functional movement and gait disorders: A matter of age?

Functional movement and gait disorders: A matter of age?

Journal: Journal of psychosomatic research

Published: July 30, 2025

Early structural hub disruption leads to premature functional adaption in multiple sclerosis.

Early structural hub disruption leads to premature functional adaption in multiple sclerosis.

Journal: Brain structure & function

Published: July 02, 2025

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 19, 2025

Baseline features and functional outcomes in primary central nervous system vasculitis: development and validation of a prognostic model.

Baseline features and functional outcomes in primary central nervous system vasculitis: development and validation of a prognostic model.

Journal: Rheumatology (Oxford, England)

Published: April 25, 2025

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Diagnostic Utility of Kappa Free Light Chain Index in Adults With Inaugural Optic Neuritis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: March 14, 2025

Specialized Large Language Model Outperforms Neurologists at Complex Diagnosis in Blinded Case-Based Evaluation.

Specialized Large Language Model Outperforms Neurologists at Complex Diagnosis in Blinded Case-Based Evaluation.

Journal: Brain sciences

Published: March 05, 2025

Showing 1-12 of 69

Last Updated: 09/26/2026